相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats
Nathalie Van den Berge et al.
BRAIN (2021)
Glutathione in the Brain
Koji Aoyama
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response
Alberto Delaidelli et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Gut-seeded α-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice
Collin Challis et al.
NATURE NEUROSCIENCE (2020)
Dopaminergic neuroprotective effects of rotigotine via 5-HT1A receptors: Possibly involvement of metallothionein expression in astrocytes
Nami Isooka et al.
NEUROCHEMISTRY INTERNATIONAL (2020)
Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection
Yao Wei et al.
NATURE COMMUNICATIONS (2020)
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates
Marie-Laure Arotcarena et al.
BRAIN (2020)
Merging the Multi-Target Effects of Phytochemicals in Neurodegeneration: From Oxidative Stress to Protein Aggregation and Inflammation
Fiona Limanaqi et al.
ANTIOXIDANTS (2020)
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
Ryo Kikuoka et al.
SCIENTIFIC REPORTS (2020)
Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine
Masato Asanuma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Brain-First versus Gut-First Parkinson's Disease: A Hypothesis
Per Borghammer et al.
JOURNAL OF PARKINSONS DISEASE (2019)
Neuroprotective effect of fermented papaya preparation by activation of Nrf2 pathway in astrocytes
Shinki Murakami et al.
NUTRITIONAL NEUROSCIENCE (2018)
The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies
Paula Perez-Pardo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Zonisamide attenuates lactacystin-induced parkinsonism in mice without affecting system xc-
Eduard Bentea et al.
EXPERIMENTAL NEUROLOGY (2017)
Phase IIb Study of Intranasal Glutathione in Parkinson's Disease
Laurie K. Mischley et al.
JOURNAL OF PARKINSONS DISEASE (2017)
Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease
Ikuko Miyazaki et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice
Ikuko Miyazaki et al.
JOURNAL OF NEUROCHEMISTRY (2016)
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPA
Masato Asanuma et al.
BMC NEUROSCIENCE (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes
Mika Takeshima et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2016)
Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals
Si Qin et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?
Christine A. Houghton et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways
Qian Zhou et al.
SCIENTIFIC REPORTS (2016)
Central nervous system uptake of intranasal glutathione in Parkinson's disease
Laurie K. Mischley et al.
NPJ PARKINSONS DISEASE (2016)
Vagotomy and Subsequent Risk of Parkinson's Disease
Elisabeth Svensson et al.
ANNALS OF NEUROLOGY (2015)
6-Hydroxydopamine and lipopolysaccharides induced DNA damage in astrocytes: Involvement of nitric oxide and mitochondria (Publication with Expression of Concern. See vol. 878, 2022)
Sonam Gupta et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2015)
Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors
Lisa Klingelhoefer et al.
NATURE REVIEWS NEUROLOGY (2015)
Striatal Astrocytes Act as a Reservoir for L-DOPA
Masato Asanuma et al.
PLOS ONE (2014)
Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial
Anthony H. V. Schapira et al.
LANCET NEUROLOGY (2013)
Suppression of neuroinflammation by astrocytic dopamine D2 receptors via αB-crystallin
Wei Shao et al.
NATURE (2013)
Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models
Ikuko Miyazaki et al.
NEUROBIOLOGY OF DISEASE (2013)
L-theanine Administration Results in Neuroprotection and Prevents Glutamate Receptor Agonist-Mediated Injury in the Rat Model of Cerebral Ischemia-Reperfusion
Mavdzhuda Zukhurova et al.
PHYTOTHERAPY RESEARCH (2013)
Health Promoting Effects of Brassica-Derived Phytochemicals: From Chemopreventive and Anti-Inflammatory Activities to Epigenetic Regulation
Anika Eva Wagner et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease
Moussa B.H. Youdim et al.
PARKINSONISM & RELATED DISORDERS (2013)
CNS delivery of l-dopa by a new hybrid glutathione-methionine peptidomimetic prodrug
Francesco Pinnen et al.
AMINO ACIDS (2012)
Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model
Li Gan et al.
JOURNAL OF NEUROSCIENCE (2012)
N-Acetylcysteine Prevents Loss of Dopaminergic Neurons in the EAAC1-/- Mouse
Ari E. Berman et al.
ANNALS OF NEUROLOGY (2011)
Ammonia increases nitric oxide, free Zn2+, and metallothionein mRNA expression in cultured rat astrocytes
Carolin Kruczek et al.
BIOLOGICAL CHEMISTRY (2011)
Dopaminergic neurons of system xc--deficient mice are highly protected against 6-hydroxydopamine-induced toxicity
Ann Massie et al.
FASEB JOURNAL (2011)
Polyphenols activate Nrf2 in astrocytes via H2O2, semiquinones, and quinones
Hilla Erlank et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Astrocyte-Derived Metallothionein Protects Dopaminergic Neurons from Dopamine Quinone Toxicity
Ikuko Miyazaki et al.
GLIA (2011)
Regulation of the System xC- Cystine/Glutamate Exchanger by Intracellular Glutathione Levels in Rat Astrocyte Primary Cultures
Todd Michael Seib et al.
GLIA (2011)
Up-regulation of metallothionein gene expression in Parkinsonian astrocytes
Gregory J. Michael et al.
NEUROGENETICS (2011)
Repeated transient sulforaphane stimulation in astrocytes leads to prolonged Nrf2-mediated gene expression and protection from superoxide-induced damage
Petra Bergstrom et al.
NEUROPHARMACOLOGY (2011)
Neuroprotective Effects of Zonisamide Target Astrocyte
Masato Asanuma et al.
ANNALS OF NEUROLOGY (2010)
Neuroprotective Herbs and Foods from Different Traditional Medicines and Diets
Marcello Iriti et al.
MOLECULES (2010)
Liposomal-Glutathione Provides Maintenance of Intracellular Glutathione and Neuroprotection in Mesencephalic Neuronal Cells
Gail D. Zeevalk et al.
NEUROCHEMICAL RESEARCH (2010)
Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1
Nadia G. Innamorato et al.
PLOS ONE (2010)
A timeline for Parkinson's disease
Christopher H. Hawkes et al.
PARKINSONISM & RELATED DISORDERS (2010)
Theanine, gamma-glutamylethylamide, a unique amino acid in tea leaves, modulates neurotransmitter concentrations in the brain striatum interstitium in conscious rats
T. Yamada et al.
AMINO ACIDS (2009)
Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: In vivo evaluation by brain microdialysis combined with ESR spectroscopy
Yuto Ueda et al.
BRAIN RESEARCH (2009)
The Nrf2-ARE cytoprotective pathway in astrocytes
Marcelo R. Vargas et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2009)
Randomized, Double-Blind, Pilot Evaluation of Intravenous Glutathione in Parkinson's Disease
Robert A. Hauser et al.
MOVEMENT DISORDERS (2009)
Approaches to Prevent Dopamine Quinone-Induced Neurotoxicity
Ikuko Miyazaki et al.
NEUROCHEMICAL RESEARCH (2009)
Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte
Pei-Chun Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Effects of theanine, a unique amino acid in tea leaves, on memory in a rat behavioral test
Takashi Yamada et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2008)
Design, synthesis and biological evaluation of glutathione peptidomimetics as components of anti-Parkinson prodrugs
Swati S. More et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Glial dysfunction in parkin null mice:: Effects of aging
Rosa M. Solano et al.
JOURNAL OF NEUROSCIENCE (2008)
Prarnipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity
Keiko Imamura et al.
NEUROSCIENCE LETTERS (2008)
Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: Novel cytoprotective mechanism against oxidative damage
Ju Hee Lim et al.
PHARMACOLOGICAL RESEARCH (2008)
Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction
Koji Aoyama et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration
Shankar J. Chinta et al.
JOURNAL OF NEUROSCIENCE (2007)
Effect of levetiracetam on molecular regulation of hippocampal glutamate and GABA transporters in rats with chronic seizures induced by amygdalar FeCl3 injection
Yuto Ueda et al.
BRAIN RESEARCH (2007)
Dopamine D3 receptor agonists for protection and repair in Parkinson's disease
Jeffrey N. Joyce et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Zonisamide improves motor function in Parkinson disease - A randomized, double-blind study
Miho Murata et al.
NEUROLOGY (2007)
Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation
Andy Y. Shih et al.
JOURNAL OF NEUROSCIENCE (2006)
Metallothionein redox cycle and function
Y. James Kang
EXPERIMENTAL BIOLOGY AND MEDICINE (2006)
Metallothioneins are multipurpose neuroprotectants during brain pathology
M Penkowa
FEBS JOURNAL (2006)
Dopamine covalently modifies and functionally inactivates parkin
MJ LaVoie et al.
NATURE MEDICINE (2005)
Dopamine D3 receptor-preferring agonists induce neurotrophic effects on mesencephalic dopamine neurons
F Du et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Dopamine agonist pergolide prevents levodopa-induced quinoprotein formation in parkinsonian striaturn and shows quenching effects on dopamine-semiquinone generated in vitro
I Miyazaki et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Effect of melatonin on temporal changes of reactive oxygen species and glutathione after MPP+ treatment in human astrocytoma U373MG cells
JI Chuang et al.
JOURNAL OF PINEAL RESEARCH (2004)
Scaffolding of Keap1 to the actin cytoskeleton controls the function of Nrf2 as key regulator of cytoprotective phase 2 genes
MI Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers
N Wakabayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult
AD Kraft et al.
JOURNAL OF NEUROSCIENCE (2004)
Potential synergy of phytochemicals in cancer prevention: Mechanism of action
RH Liu
JOURNAL OF NUTRITION (2004)
Novel therapeutic effects of the anti-convulsant, zonisamide, on Parkinson's disease
M Murata
CURRENT PHARMACEUTICAL DESIGN (2004)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Activation of transcription factor Nrf-2 and its downstream targets in response to Moloney murine leukemia virus ts1-induced thiol depletion and oxidative stress in astrocytes
W Qiang et al.
JOURNAL OF VIROLOGY (2004)
Neuron-glia communication: metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury
RS Chung et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D-3 receptor
Jeffrey N. Joyce et al.
BMC BIOLOGY (2004)
Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra
FL van Muiswinkel et al.
NEUROBIOLOGY OF AGING (2004)
Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture
K Ohta et al.
PHARMACOLOGY (2004)
Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?
M Madeja et al.
NEUROPHARMACOLOGY (2003)
Localization and photoaffinity labelling of the levetiracetam binding site in rat brain and certain cell lines
B Fuks et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Binding characteristics of [3H]ucb 30889 to levetiracetam binding sites in rat brain
M Gillard et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes
K Ohta et al.
LIFE SCIENCES (2003)
Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress
AY Shih et al.
JOURNAL OF NEUROSCIENCE (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells
ME Haque et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2003)
Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease
M Asanuma et al.
NEUROTOXICITY RESEARCH (2003)
Neuroprotective effects of the green tea components theanine and catechins
T Kakuda
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals
M Yoshioka et al.
NEUROSCIENCE RESEARCH (2002)
Selective blockade of N-type calcium channels by levetiracetam
EA Lukyanetz et al.
EPILEPSIA (2002)
Zonisamide has beneficial effects on Parkinson's disease patients
M Murata et al.
NEUROSCIENCE RESEARCH (2001)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2001)
Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease
D Blum et al.
PROGRESS IN NEUROBIOLOGY (2001)
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
RE Whitehead et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist
K Tanaka et al.
NEUROCHEMICAL RESEARCH (2001)
The multidrug resistance protein MRP1 mediates the release of glutathione disulfide from rat astrocytes during oxidative stress
J Hirrlinger et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Glutathione metabolism in brain - Metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species
R Dringen et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Bromocriptine markedly suppresses levodopa-induced abnormal increase of dopamine turnover in the parkinsonian striatum
N Ogawa et al.
NEUROCHEMICAL RESEARCH (2000)
Astrocytes provide cysteine to neurons by releasing glutathione
XF Wang et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
